Cargando…
Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway
BACKGROUND: CD300A, a type I transmembrane glycoprotein receptor, plays an important role in immune response. Recent studies have reported that CD300A is involved in the development of hematological malignancies. PURPOSE: The objective of this study was to investigate the role of CD300A in the progr...
Autores principales: | Tang, Ze, Cai, Hongfei, Wang, Rui, Cui, Youbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290927/ https://www.ncbi.nlm.nih.gov/pubmed/30573974 http://dx.doi.org/10.2147/OTT.S185521 |
Ejemplares similares
-
FSCN1 Promotes Esophageal Carcinoma Progression Through Downregulating PTK6 via its RNA-Binding Protein Effect
por: Cai, Hongfei, et al.
Publicado: (2022) -
MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/β-catenin signaling
por: Bai, Jinping, et al.
Publicado: (2019) -
Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis
por: Shukla, Samriddhi, et al.
Publicado: (2016) -
Zeylenone represses the progress of human prostate cancer by downregulating the Wnt/β-catenin pathway
por: Zeng, Shaohua, et al.
Publicado: (2018) -
Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling
por: Qiu, Hai-bo, et al.
Publicado: (2013)